H. Lundbeck A/S v. Lupin Ltd.
| H. LUNDBECK A/S, TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., TAKEDA PHARMACEUTICALS INTERNATIONAL AG and TAKEDA PHARMACEUTICALS AMERICA, INC. |
| LUPIN LTD. and LUPIN PHARMACEUTICALS, INC. |
| MACLEODS PHARMACEUTICALS LTD., MACLEODS PHARMA USA, INC., ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC GLOBAL HOLDING S.A., ALEMBIC PHARMACEUTICALS INC., ZYDUS PHARMACEUTICALS (USA) INC., CADILA HEALTHCARE LTD., SANDOZ INC., SANDOZ AG, LEK PHARMACEUTICALS, D.D. and SIGMAPHARM LABORATORIES, LLC |
| 22-1194 |
| November 29, 2021 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 20, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 36 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 35 ] filed by Appellants Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals International AG and H. Lundbeck A/S. The opening brief is due 03/21/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [825561] [JCW] [Entered: 01/20/2022 08:52 AM] |
| Filing 35 MOTION of Appellants H. Lundbeck A/S, Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals International AG to extend the time to 03/21/2022 to file brief. Service: 01/19/2022 by email. [825539] [22-1194] [George Pappas] [Entered: 01/19/2022 06:18 PM] |
Filing 34
ORDER granting motion to modify the official caption [ # 33 ] filed by Cross-Appellants Sandoz Inc. and Lek Pharmaceuticals, d.d. The revised official caption is reflected in the order. Service as of this date by the Clerk of Court. [823585] [NL] [Entered: 01/10/2022 03:15 PM]
|
| Filing 33 MOTION of Cross-Appellants Sandoz Inc. and Lek Pharmaceuticals, d.d. to modify the official caption. Service: 01/07/2022 by email. [823243] [22-1194] [Laura Lydigsen] [Entered: 01/07/2022 10:44 AM] |
| Filing 32 Notice to Appellee Sandoz AG: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [823219] [JCW] [Entered: 01/07/2022 09:24 AM] |
| Filing 31 Corrected Entry of appearance for DON J. MIZERK; MARC R. WEZOWSKI; THOMAS P. HENEGHAN; PHILIP D. SEGREST, JR.; MATTHEW KAMPS as counsel for Cross-Appellant Sigmapharm Laboratories, LLC N/A. Service: 12/30/2021 by email. [821922] [22-1194] [Donald Mizerk] [Entered: 12/30/2021 09:26 AM] |
| Filing 30 Corrected Entry of appearance for Deepro R. Mukerjee; Lance A. Soderstrom; Joseph M. Janusz; Jitendra Malik as counsel for Cross-Appellants Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/21/2021 by email. [820235] [22-1194] [Deepro Mukerjee] [Entered: 12/21/2021 12:41 PM] |
| Filing 29 Amended Certificate of Interest for Cross-Appellants Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/21/2021 by email. [820233] [22-1194] [Deepro Mukerjee] [Entered: 12/21/2021 12:37 PM] |
| Filing 28 NOTICE OF NON-COMPLIANCE: The submission of Cross-Appellants Lupin Ltd. and Lupin Pharmaceuticals, Inc., Entry of Appearance [ # 23 ], is not in compliance with the rules of this court (see attached). Compliant document due on 12/21/2021. Service as of this date by the Clerk of Court. [818447] [JCW] [Entered: 12/14/2021 10:56 AM] |
| Filing 27 Entry of appearance for George F. Pappas; Einar Stole; Brianne Bharkhda; Kurt Calia as counsel for Appellants H. Lundbeck A/S, Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG and Takeda Pharmaceuticals U.S.A., Inc.. Service: 12/13/2021 by email. [818323] [22-1194] [George Pappas] [Entered: 12/13/2021 06:02 PM] |
| Filing 26 Certificate of Interest for Appellants H. Lundbeck A/S, Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG and Takeda Pharmaceuticals U.S.A., Inc.. Service: 12/13/2021 by email. [818322] [22-1194] [George Pappas] [Entered: 12/13/2021 05:59 PM] |
| Filing 25 Docketing Statement for the Appellants H. Lundbeck A/S, Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG and Takeda Pharmaceuticals U.S.A., Inc.. Service: 12/13/2021 by email. [818321] [22-1194] [George Pappas] [Entered: 12/13/2021 05:56 PM] |
| Filing 24 Docketing Statement for the Cross-Appellants Sandoz Inc. and Lek Pharmaceuticals, d.d.. Service: 12/13/2021 by email. [818205] [22-1194] [Laura Lydigsen] [Entered: 12/13/2021 04:01 PM] |
| Filing 23 Entry of appearance for Deepro R. Mukerjee; Lance A. Soderstrom; Joseph M. Janusz; Jitendra Malik; Brian Sodikoff as counsel for Cross-Appellants Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/13/2021 by email. [818202] [22-1194] [Deepro Mukerjee] [Entered: 12/13/2021 04:00 PM] |
| Filing 22 Certificate of Interest for Cross-Appellants Sandoz Inc. and Lek Pharmaceuticals, d.d.. Service: 12/13/2021 by email. [818199] [22-1194] [Laura Lydigsen] [Entered: 12/13/2021 03:58 PM] |
| Filing 21 Certificate of Interest for Cross-Appellants Lupin Pharmaceuticals, Inc. and Lupin Ltd.. Service: 12/13/2021 by email. [818197] [22-1194] [Deepro Mukerjee] [Entered: 12/13/2021 03:57 PM] |
| Filing 20 Docketing Statement for the Cross-Appellants Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/13/2021 by email. [818195] [22-1194] [Deepro Mukerjee] [Entered: 12/13/2021 03:56 PM] |
| Filing 19 Entry of appearance for Laura A. Lydigsen; Mark H. Remus as counsel for Cross-Appellants Sandoz Inc. and Lek Pharmaceuticals, d.d.. Service: 12/13/2021 by email. [818192] [22-1194] [Laura Lydigsen] [Entered: 12/13/2021 03:53 PM] |
| Filing 18 Docketing Statement for the Cross-Appellants Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd.. Service: 12/13/2021 by email. [818121] [22-1194] [Christopher Sorenson] [Entered: 12/13/2021 01:24 PM] |
| Filing 17 NOTICE OF NON-COMPLIANCE: The submission of Cross-Appellant Sigmapharm Laboratories, LLC, Entry of Appearance [ # 14 ], is not in compliance with the rules of this court (see attached). Compliant document due on 12/20/2021. Service as of this date by the Clerk of Court. [818042] [JCW] [Entered: 12/13/2021 11:26 AM] |
| Filing 16 Docketing Statement for the Cross-Appellant Sigmapharm Laboratories, LLC. Service: 12/13/2021 by email. [818035] [22-1194] [Donald Mizerk] [Entered: 12/13/2021 11:06 AM] |
| Filing 15 Certificate of Interest for Cross-Appellant Sigmapharm Laboratories, LLC. Service: 12/13/2021 by email. [818034] [22-1194] [Donald Mizerk] [Entered: 12/13/2021 11:05 AM] |
| Filing 14 Entry of appearance for Don J. Mizerk; Marc R. Wezowski; Thomas P. Heneghan; Philip D. Segrest, Jr.; Matthew Kamps as counsel for Cross-Appellant Sigmapharm Laboratories, LLC. Service: 12/13/2021 by email. [818033] [22-1194] This document is non-compliant. See Doc No.[ # 17 ] [Donald Mizerk] [Entered: 12/13/2021 11:03 AM] |
| Filing 13 Docketing Statement for the Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. Service: 12/13/2021 by email. [818004] [22-1194] [David Abramowitz] [Entered: 12/13/2021 10:07 AM] |
| Filing 12 Official caption revised to reflect cross-appeal with 22-1246. (see attached). Service as of this date by the Clerk of Court. [817770] [JCW] [Entered: 12/10/2021 01:46 PM] |
| Filing 11 Note to File: The following cases are consolidated: 22-1194 Lead with 22-1246 Cross-Appeal. The parties must file all documents in the lead appeal only. [817768] [22-1194, 22-1246] [JCW] [Entered: 12/10/2021 01:44 PM] |
| Filing 10 Certificate of Interest for Appellees Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd.. Service: 12/10/2021 by email. [817743] [22-1194] [Christopher Sorenson] [Entered: 12/10/2021 12:40 PM] |
| Filing 9 Entry of appearance for Christopher J. Sorenson as counsel for Appellees Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd.. Service: 12/10/2021 by email. [817742] [22-1194] [Christopher Sorenson] [Entered: 12/10/2021 12:37 PM] |
| Filing 8 Docketing Statement for the Appellees Alembic Pharmaceuticals Limited, Alembic Global Holding S.A. and Alembic Pharmaceuticals Inc.. Service: 12/09/2021 by email. [817606] [22-1194] [Bradley Graveline] [Entered: 12/09/2021 08:14 PM] |
| Filing 7 Certificate of Interest for Appellees Alembic Pharmaceuticals Limited, Alembic Global Holding S.A. and Alembic Pharmaceuticals Inc.. Service: 12/09/2021 by email. [817605] [22-1194] [Bradley Graveline] [Entered: 12/09/2021 07:58 PM] |
| Filing 6 Entry of appearance for Bradley C. Graveline; Todd E. Lundell; Laura Burson, Jesse A. Salen as counsel for Appellees Alembic Pharmaceuticals Limited, Alembic Global Holding S.A. and Alembic Pharmaceuticals Inc.. Service: 12/09/2021 by email. [817604] [22-1194] [Bradley Graveline] [Entered: 12/09/2021 07:52 PM] |
| Filing 5 Certificate of Interest for Appellees Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Service: 12/09/2021 by email. [817434] [22-1194] [David Abramowitz] [Entered: 12/09/2021 11:20 AM] |
| Filing 4 Entry of appearance for Michael J. Gaertner; David B. Abramowitz; Hugh S. Balsam; Carolyn A. Blessing; Timothy F. Peterson; Jonathan B. Turpin; August M. Melcher as counsel for. Service: 12/09/2021 by email. [817433] [22-1194] [David Abramowitz] [Entered: 12/09/2021 11:19 AM] |
| Filing 3 Official caption revised to reflect cross-appeal with 22-1208. (see attached). Service as of this date by the Clerk of Court. [815567] [JCW] [Entered: 12/01/2021 11:24 AM] |
| Filing 2 Note to File: The following cases are consolidated: 22-1194 Lead with 22-1208 Cross-Appeal. The parties must file all documents in the lead appeal only. [815566] [22-1194, 22-1208] [JCW] [Entered: 12/01/2021 11:23 AM] |
| Filing 1 Appeal docketed. Received: 11/24/2021. [815036] Entry of Appearance is due on 12/13/2021. Certificate of Interest is due on 12/13/2021. Docketing Statement is due on 12/13/2021. Appellants' brief is due on 01/28/2022. [JCW] [Entered: 11/29/2021 01:45 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
